Go Pro
→ PH: Do THESE 4 things to your bank account now … (From Weiss Ratings) (Ad)tc pixel Free CRNX Stock Alerts

Crinetics Pharmaceuticals (CRNX) Short Interest Ratio & Short Volume

Crinetics Pharmaceuticals logo
$36.94 +0.24 (+0.65%)
Closing price 04:00 PM Eastern
Extended Trading
$36.99 +0.05 (+0.14%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Crinetics Pharmaceuticals Short Interest Overview

As of June 15, 2026, Crinetics Pharmaceuticals (CRNX) had a short interest of 12.86 million shares sold short, representing 12.68% of the public float. This marks a 1.72% increase in short interest since the prior report. The short interest ratio (days to cover) is 13.2, meaning it would take 13.2 days of the average trading volume of 1.25 million shares to cover all short positions.

Current Short Interest
12,856,719 shares
Previous Short Interest
12,639,107 shares
Change Vs. Previous Month
1.72%
Dollar Volume Sold Short
$451.53 million
Short Interest Ratio
13.2 Days to Cover
Last Record Date
June 15, 2026
Outstanding Shares
105,440,000 shares
Short Percent of Float
12.68%
Today's Trading Volume
883,684 shares
Average Trading Volume
1,250,465 shares
Today's Volume Vs. Average
71%
Short Selling Crinetics Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRNX Short Interest Over Time

CRNX Days to Cover Over Time

CRNX Percentage of Float Shorted Over Time

Crinetics Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202612,856,719 shares $451.53 million +1.7%12.7%13.23 $35.12
5/29/202612,639,107 shares $449.32 million -4.1%12.5%13.75 $35.55
5/15/202613,177,402 shares $484.53 million -7.0%13.0%8.14 $36.77
4/30/202614,170,153 shares $549.52 million +10.7%14.0%12.7 $38.78
4/15/202612,795,329 shares $508.87 million -20.3%12.6%12.76 $39.77
2/13/202614,453,914 shares $617.18 million +0.9%14.2%12.82 $42.70
11/14/202515,921,779 shares $679.38 million +17.6%17.8%8.56 $42.67
10/31/202513,537,482 shares $588.47 million +8.8%15.3%11.19 $43.47
10/15/202512,440,000 shares $549.23 million +0.5%14.1%8.6 $44.15
9/30/202512,380,000 shares $515.63 million -16.1%N/A9 $41.65
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
9/15/202514,750,000 shares $498.11 million +5.5%N/A14.2 $33.77
8/31/202513,980,000 shares $433.24 million +0.6%15.6%15.5 $30.99
8/15/202513,900,000 shares $427.01 million +5.5%N/A16.6 $30.72
7/31/202513,170,000 shares $376.53 million +7.6%14.7%15.7 $28.59
7/15/202512,240,000 shares $389.60 million +13.1%N/A15.4 $31.83
6/30/202510,820,000 shares $311.18 million +4.8%12.1%12.8 $28.76
6/15/202510,320,000 shares $327.87 million +1.1%11.6%11.5 $31.77
5/31/202510,210,000 shares $312.32 million +0.5%11.7%10.6 $30.59
5/15/202510,160,000 shares $317.09 million +3.3%11.7%9.8 $31.21
4/30/20259,840,000 shares $328.56 million +2.2%N/A9.7 $33.39
4/15/20259,630,000 shares $285.63 million +12.8%11.0%9.6 $29.66
3/31/20258,540,000 shares $286.43 million +9.9%9.8%7.8 $33.54
3/15/20257,770,000 shares $267.83 million -4.2%8.9%7.9 $34.47
2/28/20258,110,000 shares $290.18 million +4.0%9.3%8.6 $35.78
2/15/20257,800,000 shares $274.64 million +5.7%8.9%9.1 $35.21
1/31/20257,380,000 shares $297.41 million +2.9%N/A8.7 $40.30
1/15/20257,170,000 shares $263.35 million +3.6%N/A8.9 $36.73
12/31/20246,920,000 shares $353.82 million +10.7%N/A8.9 $51.13
12/15/20246,250,000 shares $335.38 million +4.0%N/A8.4 $53.66
11/30/20246,010,000 shares $343.77 million -7.5%N/A8.4 $57.20
11/15/20246,500,000 shares $355.68 million -6.3%N/A9.1 $54.72
10/31/20246,940,000 shares $388.36 million +5.3%N/A10.5 $55.96
10/15/20246,590,000 shares $379.58 million -2.8%N/A9.8 $57.60
9/30/20246,780,000 shares $346.46 million +11.0%N/A10.3 $51.10
9/15/20246,110,000 shares $328.72 million -1.8%N/A8.2 $53.80
8/31/20246,220,000 shares $330.03 million -3.9%N/A8.3 $53.06
8/15/20246,470,000 shares $339.87 million +5.7%N/A8 $52.53
7/31/20246,120,000 shares $325.09 million -7.0%N/A6.6 $53.12
7/15/20246,580,000 shares $356.24 million +12.1%N/A7 $54.14
6/30/20245,870,000 shares $262.92 million +0.2%N/A6.5 $44.79
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
6/15/20245,860,000 shares $265.63 million +16.5%N/A6.7 $45.33
5/31/20245,030,000 shares $223.38 million +2.4%N/A5.6 $44.41
5/15/20244,910,000 shares $247.91 million No ChangeN/A5.5 $50.49
4/30/20244,910,000 shares $215.16 million -5.9%N/A5.9 $43.82
4/15/20245,220,000 shares $228.01 million +6.3%N/A6.5 $43.68
3/31/20244,910,000 shares $229.84 million -2.0%N/A6.1 $46.81
3/15/20245,010,000 shares $195.04 million +5.7%N/A6.7 $38.93
2/29/20244,740,000 shares $194.06 million +5.1%N/A6 $40.94
2/15/20244,510,000 shares $166.51 million -11.1%N/A5.8 $36.92
1/31/20245,070,000 shares $184.95 million -0.8%N/A6.2 $36.48
1/15/20245,110,000 shares $190.04 million -0.6%N/A6 $37.19
12/31/20235,140,000 shares $182.88 million -13.6%N/A5.9 $35.58
12/15/20235,950,000 shares $205.04 million -6.7%N/A6.4 $34.46
11/30/20236,380,000 shares $202.82 million +2.9%N/A4 $31.79
11/15/20236,200,000 shares $179.06 million -7.6%N/A4 $28.88
10/31/20236,710,000 shares $196.54 million -1.5%N/A4.4 $29.29
10/15/20236,810,000 shares $198.24 million +16.4%N/A4.7 $29.11
9/30/20235,850,000 shares $173.98 million +43.7%N/A4.1 $29.74
9/15/20234,070,000 shares $120.02 million -10.4%N/A3.1 $29.49
8/31/20234,540,000 shares $78.63 million +21.4%N/A5.2 $17.32
8/15/20233,740,000 shares $62.53 million +11.0%N/A7.9 $16.72
7/31/20233,370,000 shares $64.03 million -2.9%N/A7.2 $19.00
7/15/20233,470,000 shares $70.68 million +1.5%N/A7.2 $20.37
6/30/20233,420,000 shares $61.63 million +4.0%N/A7.6 $18.02
6/15/20233,290,000 shares $68.33 million No ChangeN/A7 $20.77
5/31/20233,290,000 shares $71.82 million -4.4%N/A7.2 $21.83
5/15/20233,440,000 shares $76.82 million -18.9%N/A7.7 $22.33
4/30/20234,240,000 shares $82.85 million -1.2%N/A9.9 $19.54
4/15/20234,290,000 shares $68.34 million -6.3%N/A10.6 $15.93
3/31/20234,580,000 shares $73.55 million +12.3%N/A10.8 $16.06
3/15/20234,080,000 shares $70.14 million +12.1%N/A10.1 $17.19
2/28/20233,640,000 shares $71.49 million +7.4%N/A8.9 $19.64
2/15/20233,390,000 shares $67.70 million -4.0%N/A8.8 $19.97
1/31/20233,530,000 shares $69.22 million -5.4%N/A9.3 $19.61
1/15/20233,730,000 shares $67.29 million No ChangeN/A11.1 $18.04
12/30/20223,730,000 shares $68.26 million +3.3%N/A11.7 $18.30
12/15/20223,610,000 shares $58.63 million -5.3%N/A12.1 $16.24
11/30/20223,810,000 shares $68.08 million -1.3%N/A14.3 $17.87
11/15/20223,860,000 shares $70.41 million -3.7%N/A14.3 $18.24
10/31/20224,010,000 shares $74.02 million -1.7%N/A14.4 $18.46
10/15/20224,080,000 shares $72.05 million +1.5%N/A15 $17.66
9/30/20224,020,000 shares $78.95 million +3.1%N/A15.6 $19.64
9/15/20223,900,000 shares $83.34 million +9.9%N/A14 $21.37
8/31/20223,550,000 shares $67.02 million +13.4%N/A12.3 $18.88
8/15/20223,130,000 shares $70.02 million +12.6%N/A10.3 $22.37
7/31/20222,780,000 shares $53.40 million -2.1%N/A8.9 $19.21
7/15/20222,840,000 shares $58.82 million -1.1%N/A9 $20.71
6/30/20222,870,000 shares $53.53 million +5.9%N/A8.3 $18.65
6/15/20222,710,000 shares $47.86 million +8.8%N/A7.4 $17.66
5/31/20222,490,000 shares $41.71 million +2.1%N/A7.5 $16.75
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
5/15/20222,440,000 shares $45.75 million +11.9%N/A7.9 $18.75
4/30/20222,180,000 shares $44.30 million -18.1%N/A7.9 $20.32
4/15/20222,660,000 shares $69.16 million +0.8%N/A9.5 $26.00
3/31/20222,640,000 shares $57.95 million +13.3%N/A10.7 $21.95
3/15/20222,330,000 shares $44.46 million +10.4%6.2%9.6 $19.08
2/28/20222,110,000 shares $42.24 million +0.5%5.6%8.1 $20.02
2/15/20222,100,000 shares $41.43 million +23.5%5.6%7.6 $19.73
1/31/20221,700,000 shares $32.11 million +39.3%N/A6.1 $18.89
1/15/20221,220,000 shares $29.29 million -6.9%N/A4.3 $24.01
12/31/20211,310,000 shares $37.22 million +12.0%N/A4.1 $28.41
12/15/20211,170,000 shares $29.45 million +18.1%N/A3.8 $25.17
11/30/2021990,900 shares $27.07 million -1.9%N/A3.6 $27.32
11/15/20211,010,000 shares $27.26 million -13.7%N/A3.8 $26.99
10/29/20211,170,000 shares $29.17 million -17.0%3.4%4.4 $24.93
10/15/20211,410,000 shares $27.48 million -4.7%4.8%5.7 $19.49
9/30/20211,480,000 shares $31.15 million +16.5%5.0%8.5 $21.05
9/15/20211,270,000 shares $29.85 million -3.1%4.3%6.7 $23.50
8/31/20211,310,000 shares $30.88 million +5.7%4.7%6.7 $23.57
8/13/20211,240,000 shares $27.60 million -4.6%4.4%6.3 $22.26
7/30/20211,300,000 shares $23.37 million -0.8%4.9%7.8 $17.98
7/15/20211,310,000 shares $25.82 million -3.7%4.5%8.2 $19.71
6/30/20211,360,000 shares $25.64 million +2.3%4.7%7.9 $18.85

CRNX Short Interest - Frequently Asked Questions

Short interest is the volume of Crinetics Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 12,856,719 shares of CRNX short. 12.68% of Crinetics Pharmaceuticals' shares are currently sold short. Learn More on Crinetics Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRNX shares currently have a short interest ratio of 13.2. Learn More on Crinetics Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.68% of Crinetics Pharmaceuticals' floating shares are currently sold short.

Crinetics Pharmaceuticals saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 12,856,719 shares, an increase of 1.7% from the previous total of 12,639,107 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

12.68% of Crinetics Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Crinetics Pharmaceuticals: Ascendis Pharma A/S (5.31%), BridgeBio Pharma, Inc. (15.13%), Axsome Therapeutics, Inc. (8.03%), Elanco Animal Health Incorporated (7.20%), Arrowhead Pharmaceuticals, Inc. (8.65%), Dr. Reddy's Laboratories Ltd (2.79%), Summit Therapeutics PLC (28.74%), Krystal Biotech, Inc. (12.25%), Cytokinetics, Incorporated (12.18%), Nuvalent, Inc. (4.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.25 billion), Invesco QQQ ($51.70 billion), iShares Russell 2000 ETF ($25.75 billion), Sandisk Corporation ($23.00 billion), Western Digital Corporation ($17.29 billion), Nebius Group N.V. ($13.25 billion), SPDR S&P Biotech ETF ($10.78 billion), KLA Corporation ($10.45 billion), Salesforce Inc. ($9.71 billion), and VanEck Semiconductor ETF ($9.01 billion). View all of the most shorted stocks.

Short selling CRNX is an investing strategy that aims to generate trading profit from Crinetics Pharmaceuticals as its price is falling. CRNX shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Crinetics Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRNX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRNX, twice per month. The most recent reporting period available is June, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CRNX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:CRNX) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel